Sampatrilat. UK 81252.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D015507:Drugs, Investigational / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D010450:Endopeptidases / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008698:Mesylates / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011918:Rats, Inbred SHR; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D015507:Drugs, Investigational; D008698:Mesylates; D011480:Protease Inhibitors; D014443:Tyrosine; D010450:Endopeptidases; C111998:sampatrilat